| 2026-07-30 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2026-07-21 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2026-05-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2026-05-14 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-05-14 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2026-04-07 | Herabstufung | Citizens | Mkt Outperform → Mkt Perform |
| 2026-04-02 | Herabstufung | UBS | Buy → Neutral |
| 2026-03-27 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2026-03-12 | Resumed | Piper Sandler | Neutral |
| 2026-03-09 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-11-20 | Bestätigt | Needham | Buy |
| 2025-06-16 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-05-23 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-04-08 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2025-03-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-02-03 | Eingeleitet | Wells Fargo | Underweight |
| 2025-01-21 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-01-13 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-23 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-09-05 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-07-25 | Resumed | KeyBanc Capital Markets | Sector Weight |
| 2024-05-21 | Bestätigt | Needham | Buy |
| 2024-05-21 | Bestätigt | Oppenheimer | Outperform |
| 2024-05-21 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-03-27 | Resumed | Raymond James | Outperform |
| 2023-12-08 | Resumed | BofA Securities | Buy |
| 2023-11-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-10-24 | Eingeleitet | Seaport Research Partners | Buy |
| 2023-10-20 | Resumed | UBS | Buy |
| 2023-09-22 | Eingeleitet | UBS | Buy |
| 2023-07-27 | Eingeleitet | DA Davidson | Buy |
| 2023-06-28 | Eingeleitet | B. Riley Securities | Buy |
| 2023-05-04 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-04-11 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-03-21 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-02-23 | Hochstufung | Piper Sandler | Underweight → Neutral |
| 2023-02-17 | Eingeleitet | Credit Suisse | Outperform |
| 2023-01-12 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-12-13 | Eingeleitet | Citigroup | Buy |
| 2022-11-11 | Eingeleitet | JP Morgan | Neutral |
| 2022-09-29 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2022-07-27 | Resumed | Oppenheimer | Perform |
| 2022-05-20 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-25 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2022-04-20 | Eingeleitet | Citigroup | Buy |
| 2022-04-14 | Eingeleitet | The Benchmark Company | Hold |
| 2022-03-01 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-02-17 | Bestätigt | BofA Securities | Buy |
| 2022-02-17 | Bestätigt | JMP Securities | Mkt Outperform |
| 2022-02-17 | Bestätigt | Morgan Stanley | Overweight |
| 2022-02-17 | Bestätigt | Needham | Buy |
| 2022-02-17 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2022-02-17 | Bestätigt | Truist | Buy |
| 2022-02-17 | Bestätigt | Wolfe Research | Outperform |
| 2022-02-16 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-11-12 | Bestätigt | Needham | Buy |
| 2021-10-25 | Eingeleitet | Berenberg | Buy |
| 2021-10-21 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-09-08 | Eingeleitet | Piper Sandler | Neutral |
| 2021-08-11 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-08-11 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-06-28 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-06-08 | Eingeleitet | Atlantic Equities | Overweight |
| 2021-05-27 | Resumed | RBC Capital Mkts | Outperform |
| 2021-04-27 | Eingeleitet | Needham | Buy |
| 2021-04-06 | Eingeleitet | Evercore ISI | Outperform |
| 2021-04-01 | Eingeleitet | Wolfe Research | Outperform |
| 2020-12-09 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-08-07 | Bestätigt | Needham | Buy |
| 2020-06-29 | Bestätigt | SunTrust | Buy |
| 2020-06-09 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-05-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-17 | Hochstufung | Rosenblatt | Sell → Neutral |
| 2019-04-29 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2019-03-27 | Eingeleitet | Macquarie | Neutral |
| 2019-03-20 | Eingeleitet | Guggenheim | Buy |
| 2019-02-20 | Herabstufung | Rosenblatt | Neutral → Sell |
| 2018-12-19 | Eingeleitet | Citigroup | Buy |
| 2018-11-21 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2018-09-14 | Eingeleitet | Wedbush | Outperform |
| 2018-06-07 | Bestätigt | Needham | Buy |
| 2018-05-10 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2018-03-23 | Eingeleitet | Goldman | Neutral |
| 2018-02-15 | Bestätigt | Needham | Buy |
| 2018-01-04 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2017-11-24 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-11-09 | Herabstufung | Wedbush | Outperform → Neutral |
WIX
